NCT06236139
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Metastatic Prostate Adenocarcinoma
Explore clinical trials studying Metastatic Prostate Adenocarcinoma. Study availability and eligibility vary by location and protocol.
25 public trials
13 recruiting studies
Metastatic Prostate Adenocarcinoma trial results
NCT06145633
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06931340
- Conditions
- Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Kaiser Permanente Dublin Dublin, California, United States
- Kaiser Permanente-Fremont Fremont, California, United States
NCT07200830
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Providence Alaska Medical Center Anchorage, Alaska, United States
- AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
Recruiting
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
NCT05113537
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT06039371
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT05168618
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
Recruiting
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT06616155
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Rush University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
NCT04704505
- Conditions
- Castration-Resistant, Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma
- Locations
-
- Amber Michalik Baltimore, Maryland, United States
- Moinhos de Vento Hospital Porto Alegre, Brazil
NCT04734730
- Conditions
- Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States